If you’re one of the many people using Ozempic (semaglutide) to manage type 2 diabetes or for weight loss under medical ...

A string of blunders led to the value of Novo Nordisk dropping £52bn last week. Could a new weight-loss pill help it regain ...

Once aimed at diabetes patients, drugs like Ozempic are famous for bringing about rapid weight loss. But the injections often ...

Eris Lifesciences is using its growing insulin business to position itself as a serious contender in India’s fast-expanding ...

Muscle and strength loss in human aging, also known as sarcopenia, can result in trouble with balance and walking, according to the Cleveland Clinic. It’s a condition often linked to obesity, ...

Eris Lifesciences plans to lead in generic semaglutide drugs. The patent for Novo Nordisk's drug expires in India in March ...

As Sky News research revealed thousands of severely obese patients are facing severely delayed treatment, here we look at the ...

Coming off GLP-1 drugs doesn’t have to mean inevitable weight gain. Giulia Crouch asks doctors what you can do to keep it off ...

However, Dr Debra Marcos, Medical Director at doctor-led clinic Weight Medics, notes that if used in the proper way, combined ...

Nutritionists say it’s possible – and all without pricey prescription injections and weight loss supplements. Amira Arasteh reports ...

FAT jabs are not a “quick fix” and patients must be followed up for at least a year to keep the weight off, the NHS watchdog ...

When it was riding high, Novo Nordisk could have done M&A to reduce its dependence on obesity treatments. It didn’t.